John Oyler - Jun 23, 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
ONC
Transactions as of
Jun 23, 2025
Transactions value $
-$830,360
Form type
4
Date filed
6/25/2025, 05:06 PM
Previous filing
Jun 18, 2025
Next filing
Jul 11, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OYLER JOHN Chief Executive Officer, Director C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 2025-06-25 0001042047

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale -$804K -3.07K -96.85% $261.57 100 Jun 23, 2025 Direct F6, F7
transaction ONC American Depositary Shares Sale -$26.3K -100 -100% $262.90 0 Jun 23, 2025 Direct F6, F7
holding ONC Ordinary Shares 8.17M Jun 23, 2025 Direct
holding ONC Ordinary Shares 482K Jun 23, 2025 See Footnote F1
holding ONC Ordinary Shares 7.72M Jun 23, 2025 See Footnote F2
holding ONC Ordinary Shares 28.2M Jun 23, 2025 See Footnote F3
holding ONC Ordinary Shares 9.55M Jun 23, 2025 See Footnote F4
holding ONC Ordinary Shares 102K Jun 23, 2025 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
F5 These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
F6 Each American Depositary Share represents 13 Ordinary Shares
F7 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.